Author: Milbury K1, Mallaiah S2, Lopez G2, Liao Z2, Yang C2, Carmack C2, Chaoul A2, Spelman A2, Cohen L2.
1The University of Texas MD Anderson Cancer Center, Houston, TX, USA email@example.com. 2The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Conference/Journal: Integr Cancer Ther.
Date published: 2015 Apr 27
Other: Word Count: 237
The primary purpose of this study was to establish the feasibility of a couple-based Vivekananda Yoga (VKC) intervention in lung cancer patients and caregivers. Secondly, we examined preliminary efficacy regarding quality of life (QOL) outcomes.
In this single-arm feasibility trial, patients with lung cancer undergoing radiotherapy and their caregivers participated in a 15-session VKC program that focused on the interconnectedness of the dyad. We assessed pre-and post-intervention levels of fatigue, sleep disturbances, psychological distress, overall QOL, spirituality, and relational closeness. We tracked feasibility data, and participants completed program evaluations.
We approached 28 eligible dyads of which 15 (53%) consented and 9 (60%) completed the intervention. Patients (mean age = 73 years, 63% female, all stage III) and caregivers (mean age = 62 years, 38% female, 63% spouses) completed a mean of 10 sessions and 95.5% of them rated the program as very useful. Paired t tests revealed a significant increase in patients' mental health (d = 0.84; P = .04) and a significant decrease in caregivers' sleep disturbances (d = 1.44; P = .02). Although not statistically significant, for patients, effect sizes for change scores were medium for benefit finding and small for distress (d = 0.65 and 0.37, respectively). For caregivers, medium effects were found for improvement in physical functioning (d = 0.50).
This novel supportive care program appears to be safe, feasible, acceptable, and subjectively useful for lung cancer patients and their caregivers and lends support for further study.
© The Author(s) 2015.
dyadic intervention; family caregivers; feasibility; mind-body medicine; non-small-cell lung cancer; quality of life